Stay In The Know

Join The Discord & Study Up With The Foundation Video Series https://tradejournal.co/connect

News

What to Watch For as Donald Trump’s Impeachment Trial Begins

https://www.nytimes.com/interactive/2021/02/08/us/politics/trump-second-impeachment-timeline.html?action=click&module=Spotlight&pgtype=Homepage

Coronavirus Variants and Mutations

https://www.nytimes.com/interactive/2021/health/coronavirus-variant-tracker.html?action=click&module=Top%20Stories&pgtype=Homepage

Corona tracker

https://graphics.reuters.com/world-coronavirus-tracker-and-maps/countries-and-territories/mexico/

KLM Conducts First Commercial Flight with Synthetic Fuel

https://www.morningbrew.com/daily/stories/2021/02/08/klm-conducts-first-commercial-flight-synthetic-fuel

Live Stream

Timestamps in video description

https://youtu.be/FfpOQhnCHJQ

Notes / Research / Recap / Additional Video

️I accredit my $2k win today on the sleding.

Watchlist

65% 530mc 156f

February 8, 2021 04:54 AM ET (BZ Newswire) -- Biotech

Ocugen Inc (NASDAQ:OCGN) shares traded 74.1% higher at $9.14 at press time in the pre-market session on Monday.

The surge comes as the biopharmaceutical company announced the sale of 3 million shares of its common stock in a registered direct offering to healthcare-focused institutional investors.

The offering is priced at $7.65 per share, a premium of 45.7% on Ocugen’s Friday closing price. The company is expected to raise $23 million from the sale.

Ocugen shares began surging last week over news that the company had executed a definitive agreement with India's Bharat Biotech to commercialize the latter's Covaxin COVID-19 vaccine candidate.

The Pennsylvania-based company also got a ratings upgrade to Buy from HC Wainwright & Co. last week, with a price target of $4.50.

190% 33mc 2f

Comstock Holding Co (NASDAQ:CHCI) shares rose 83.17% to $7.73 during Monday's after-market session. Trading volume for this security closed at 1.8 million, accounting for 854.72% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $62.4 million.

50% 71mc 16f

• Iterum Therapeutics plc (NASDAQ:ITRM) shares rose 59.7% to $2.46 in pre-market trading after surging more than 15% on Monday. Iterum Therapeutics, last week, agreed to purchase on a firm commitment basis 8,695,653 ordinary shares at a public offering price of $1.15 per share.

40% 200mc 102f

??

70% 39mc 4f

60% 20mc 22f

170% 270mc 16f

Free Gap Scanner + Win 2 Free Stocks 🎉 (Each Up To $1600) 👉👉 http://enzlo.com/webull

Best Savings Account Ever! 😍 Win $10 Million - Use Code: WINKLER 👉👉 http://enzlo.com/save

Watchlist 👉👉 https://tradejournal.co/post/tuesday-pre-market-top-gainers-408/